Boston Scientific is snatching up Cosman Medical to get its hands on the company’s radiofrequency ablation systems to expand its neuromodulation portfolio.…

A Cancer Research UK funded study has found an antimalaria drug could reverse tumor hypoxia and complement radiotherapy in killing cancer cells.

Gene editing pioneer Sangamo BioSciences has its sights set on curing hemophilia, a rare disorder in which the blood doesn't clot normally.

The company aims to “fundamentally transform cancer care,” it said, using its multi-biomarker tech platforms to detect cancer earlier than traditional tests.…

Merck has shocked ALK-Abello by returning the rights to three sublingual allergy immunotherapy tablets, triggered an 18% drop in the Danish firm's share…

Researchers at MIT have published a paper about an adhesive hydrogel patch that could be used in the treatment of colorectal tumors after surgery.

Duke University could be handed as much as $19 million from the National Institutes of Health to manage first-in-human studies for conditions such as Alzheimer…

We can rebuild him; we have the technology--but Americans question if we should in a new survey designed to assess attitudes to modern biotechnology advances.